Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Management of hepatocellular carcinoma.

Cormier JN, Thomas KT, Chari RS, Pinson CW.

J Gastrointest Surg. 2006 May;10(5):761-80. Review.

PMID:
16713550
2.

Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.

Liu C, Sun L, Xu J, Zhao Y.

World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z.

3.

Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation.

Fisher RA, Maroney TP, Fulcher AS, Maluf D, Clay JA, Wolfe LG, Dawson S 3rd, Cotterell A, Stravitz RT, Luketic VA, Shiffman M, Sterling RK, Posner MP.

Clin Transplant. 2002;16 Suppl 7:52-8.

PMID:
12372045
4.

Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.

Fisher RA, Maluf D, Cotterell AH, Stravitz T, Wolfe L, Luketic V, Sterling R, Shiffman M, Posner M.

Clin Transplant. 2004 Oct;18(5):502-12.

PMID:
15344951
5.

Surgical resection and liver transplantation for hepatocellular carcinoma.

Akoad ME, Pomfret EA.

Clin Liver Dis. 2015 May;19(2):381-99. doi: 10.1016/j.cld.2015.01.007. Epub 2015 Mar 2. Review.

PMID:
25921669
6.

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.

Cheng JC, Chuang VP, Cheng SH, Huang AT, Lin YM, Cheng TI, Yang PS, You DL, Jian JJ, Tsai SY, Sung JL, Horng CF.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):435-42.

PMID:
10802371
7.
8.

Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients.

Huang YH, Wu JC, Chau GY, Lui WY, King KL, Chiang JH, Yen SH, Sheng WY, Hou MC, Lu CL, Chang FY, Lee SD.

Eur J Gastroenterol Hepatol. 1999 Mar;11(3):315-21.

PMID:
10333206
9.

Treatment options in hepatocellular carcinoma today.

Livraghi T, Mäkisalo H, Line PD.

Scand J Surg. 2011;100(1):22-9. Review.

PMID:
21482502
10.

Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.

Yoon HM, Kim JH, Kim EJ, Gwon DI, Ko GY, Ko HK.

J Vasc Interv Radiol. 2013 Nov;24(11):1639-46. doi: 10.1016/j.jvir.2013.06.017. Epub 2013 Aug 17.

PMID:
23962438
11.

Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.

Han K, Kim JH.

World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327. Review.

12.

Nonsurgical treatment of hepatocellular carcinoma.

Llovet JM, Sala M, Bruix J.

Liver Transpl. 2000 Nov;6(6 Suppl 2):S11-5. Review.

13.
14.
15.

Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.

Green TJ, Rochon PJ, Chang S, Ray CE Jr, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J.

J Vasc Interv Radiol. 2013 Nov;24(11):1613-22. doi: 10.1016/j.jvir.2013.07.024. Epub 2013 Sep 20.

PMID:
24060436
16.

Treatment of hepatocellular carcinoma.

Blum HE.

Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):129-45. Review.

PMID:
15757809
17.

Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma.

Ashoori N, Paprottka P, Trumm C, Bamberg F, Kolligs FT, Rentsch M, Reiser MF, Jakobs TF.

Digestion. 2012;85(1):18-26. doi: 10.1159/000334714. Epub 2011 Dec 8.

PMID:
22156507
18.

Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.

Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M.

World J Gastroenterol. 2013 Sep 14;19(34):5622-32. doi: 10.3748/wjg.v19.i34.5622.

19.

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.

Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM, Schwartz ME.

Ann Surg. 2002 Apr;235(4):533-9.

20.

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.

Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.

Liver Transpl. 2004 Dec;10(12):1478-86.

Supplemental Content

Support Center